Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million
COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced…
ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA
SHANGHAI, June 16, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
OCI Global Receives U.S. Regulatory Approval for the Sale of its Global Methanol Business to Methanex Corporation
AMSTERDAM, June 12, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI), ("OCI", the…
New Betting Sites for UK Players – BetFoxx Leads Recommendations as Most Exciting New UK Sportsbook
New York City, NY, June 07, 2025 (GLOBE NEWSWIRE) -- Welcome to…
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE…